Stockscreener 앱 받기
3.96
3.94%
0.15
Zentalis Pharmaceuticals Inc 주식(ZNTL)의 최신 뉴스
Zentalis Pharmaceuticals Inc (ZNTL): Worth A Small Bite At $3.81 - Stocks Register
Eventide Asset Management's Strategic Reduction in Zentalis Phar - GuruFocus.com
Vanguard Group Inc's Strategic Reduction in Zentalis Pharmaceuti - GuruFocus.com
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of "Hold" from Analysts - MarketBeat
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Immunome (NASDAQ: IMNM) Acquires Zentalis Pharmaceuticals’ Licensed Assets IMMUNOME, Inc. made a recent significant move on October 25, 2024, by acquiring Zentalis Pharmaceuticals, Inc.’s Licensed Assets. This acquisition was carried out thr - Defense World
Zentalis stock hits 52-week low at $2.82 amid market challenges - Investing.com Canada
State Street Corp's Strategic Reduction in Zentalis Pharmaceuticals Holdings - Yahoo Finance
Perhaps timely catching Zentalis Pharmaceuticals Inc (ZNTL) would be a good idea - SETE News
Zentalis Pharmaceuticals Inc [ZNTL] Stock sold by Insider Vultaggio Vincent for $5098.0 - Knox Daily
Several Insiders Invested In Zentalis Pharmaceuticals Flagging Positive News - Yahoo Finance
Balance Sheet Insights: Zentalis Pharmaceuticals Inc (ZNTL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Zentalis Pharmaceuticals Inc (ZNTL)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Short Interest in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Decreases By 26.2% - MarketBeat
ZNTL Shares Experience Decline in Value - Knox Daily
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives $10.78 Consensus Price Target from Brokerages - MarketBeat
A History of Outperforming Analyst Forecasts and Beating the Odds: Zentalis Pharmaceuticals Inc (ZNTL) - SETE News
Zentalis Pharmaceuticals Inc [ZNTL] Insider Vultaggio Vincent sells 1,603 Shares – Company Insider Activity - Knox Daily
Results from Zentalis Pharmaceuticals Inc (ZNTL) show risk - US Post News
Zentalis Pharmaceuticals Inc: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
FMR LLC Adjusts Its Stake in Zentalis Pharmaceuticals Inc - Yahoo Finance
Stock Market Recap: Zentalis Pharmaceuticals Inc (ZNTL) Concludes at 3.37, a 5.31 Surge/Decline - The Dwinnex
Zentalis Pharmaceuticals executive sells over $5,000 in company stock By Investing.com - Investing.com Canada
Zentalis Pharmaceuticals executive sells over $5,000 in company stock - Investing.com India
ZNTL’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
We Think Zentalis Pharmaceuticals (NASDAQ:ZNTL) Needs To Drive Business Growth Carefully - Simply Wall St
Zentalis (ZNTL) Plunges More Than 70% in 3 Months: Here's Why - MSN
Recent Insider Activity Could Benefit Zentalis Pharmaceuticals Inc (ZNTL) - Knox Daily
A Look at Zentalis Pharmaceuticals Inc (ZNTL) Shares in the Recent Past Indicates Growth - SETE News
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Holdings Raised by Renaissance Technologies LLC - MarketBeat
Results from Zentalis Pharmaceuticals Inc (ZNTL) show potential - US Post News
Zentalis Pharma (NASDAQ:ZNTL) Stock Quotes, Forecast and News Summary - Benzinga
Decheng Capital LLC Has $12.56 Million Stock Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - MarketBeat
Holdings of Zentalis Pharmaceuticals Inc (ZNTL) are aligned with the stars - SETE News
Analyzing Ratios: Zentalis Pharmaceuticals Inc (ZNTL)’s Financial Story Unveiled - The Dwinnex
Intech Investment Management LLC Raises Position in Zscaler, Inc. (NASDAQ:ZS) - MarketBeat
Beyond The Numbers: 7 Analysts Discuss Zevra Therapeutics Stock - Benzinga
Should investors be concerned about Zura Bio Ltd (ZURA)? - US Post News
Holdings of Zevra Therapeutics Inc (ZVRA) are aligned with the stars - SETE News
Financial Metrics Unveiled: Zevra Therapeutics Inc (ZVRA)’s Key Ratios in the Spotlight - The Dwinnex
Zevra Therapeutics price target raised to $21 from $19 at Roth MKM - TipRanks
Zapata Computing Holdings Inc. (ZPTA) requires closer examination - US Post News
Zscaler, Inc. (NASDAQ:ZS) Shares Sold by ProShare Advisors LLC - MarketBeat
ZIVO Bioscience (NASDAQ:ZIVOW) Shares Down 60% - Defense World
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Acquired by XTX Topco Ltd - MarketBeat
Understanding ZVRA’s financial ratios: A beginner’s guide - US Post News
A year in review: Zentalis Pharmaceuticals Inc (ZNTL)’s performance in the last year - US Post News
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Sold by Federated Hermes Inc. - MarketBeat
Meiji Yasuda Asset Management Co Ltd. Sells 285 Shares of Zscaler, Inc. (NASDAQ:ZS) - Defense World
Massachusetts Financial Services Co. MA Invests $25.29 Million in Zscaler, Inc. (NASDAQ:ZS) - Defense World
Zenas BioPharma CEO acquires $360k worth of company shares - Investing.com
Zevra Therapeutics’ MIPLYFFA Wins FDA Approval for NPC - TipRanks
Zevra Therapeutics rises on US FDA approval for rare genetic disease treatment - XM
Zevra Therapeutics price target raised to $20 from $18 at H.C. Wainwright - TipRanks
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy - Benzinga
A stock that deserves closer examination: Zura Bio Ltd (ZURA) - US Post News
US FDA approves Zevra's genetic disorder treatment - XM
FY2024 EPS Estimates for Zevra Therapeutics, Inc. Reduced by Analyst (NASDAQ:ZVRA) - MarketBeat
Bank of New York Mellon Corp Boosts Position in Zumiez Inc. (NASDAQ:ZUMZ) - Defense World
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Purchased by Bank of New York Mellon Corp - Defense World
Zenas BioPharma’s $225 Million IPO - Global Legal Chronicle
Zura Bio Ltd [ZURA] Director makes an insider sale of 3,800,000 shares worth 10,260,000. - Knox Daily
1.47%
6.86%
자본화:
|
볼륨(24시간):